Paper9510340
Casodex (bicalutamide) 150-mg monotherapy compared with castration in patients with previously untreated nonmetastatic prostate cancer: results from two multicenter randomized trials at a median follow-up of 4 years.
Iversen P and 9 others. Urology, 1998. Cited by 119 papers, by iCite.
Cite this record
ConductScience Library. Casodex (bicalutamide) 150-mg monotherapy compared with castration in patients with previously untreated nonmetastatic prostate cancer: results from two multicenter randomized trials at a median follow-up of 4 years. Papers, record 9510340. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/9510340
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
Casodex (bicalutamide) 150-mg monotherapy compared with castration in patients with previously untreated nonmetastatic prostate cancer: results from two multicenter randomized trials at a median follow-up of 4 years.
- PubMed
- Publication types
- Clinical Trial, Comparative Study, Journal Article, Multicenter Study, Randomized Controlled Trial
- PubMed
Topics19
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Androgen Antagonists | Major topic |
| Anilides | Major topic |
| Antineoplastic Agents, Hormonal | Major topic |
| Castration | Major topic |
| Goserelin | Major topic |
| Prostatic Neoplasms | Major topic |
| Aged | |
| Aged, 80 and over | |
| Disease Progression | |
| Double-Blind Method | |
| Follow-Up Studies | |
| Humans | |
| Male | |
| Middle Aged | |
| Nitriles | |
| Quality of Life | |
| Survival Rate | |
| Time Factors | |
| Tosyl Compounds |
Source PubMed
Cited by33
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 119 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 40752653 | Long-Term Results of NRG/RTOG 9601, a Randomized Trial of Radiation With or Without Antiandrogens in Patients Receiving Salvage Prostate Bed Radiation Therapy Postprostatectomy. | Int J Radiat Oncol Biol Phys | 2025 | https://conductscience.org/library/papers/40752653 | PubMed |
| 36347548 | How can we best manage biochemical failure after radical prostatectomy? | Investig Clin Urol | 2022 | https://conductscience.org/library/papers/36347548 | PubMed |
| 33402834 | A Clinical Evaluation of Enzalutamide in Metastatic Castration-Sensitive Prostate Cancer: Guiding Principles for Treatment Selection and Perspectives on Research. | Onco Targets Ther | 2020 | https://conductscience.org/library/papers/33402834 | PubMed |
| 28653121 | [Radiation with additional antiandrogen therapy in recurrent prostate cancer]. | Strahlenther Onkol | 2017 | https://conductscience.org/library/papers/28653121 | PubMed |
| 28646463 | Patterns of failure after radical prostatectomy in prostate cancer - implications for radiation therapy planning after 68Ga-PSMA-PET imaging. | Eur J Nucl Med Mol Imaging | 2017 | https://conductscience.org/library/papers/28646463 | PubMed |
| 28146658 | Radiation with or without Antiandrogen Therapy in Recurrent Prostate Cancer. | N Engl J Med | 2017 | https://conductscience.org/library/papers/28146658 | PubMed |
| 27141178 | Saudi oncology society and Saudi urology association combined clinical management guidelines for prostate cancer. | Urol Ann | 2016 | https://conductscience.org/library/papers/27141178 | PubMed |
| 26024831 | A Randomized Control Trial Comparing the Efficacy of Antiandrogen Monotherapy: Flutamide vs. Bicalutamide. | Horm Cancer | 2015 | https://conductscience.org/library/papers/26024831 | PubMed |
| 25829707 | Can Subepididymal Orchiectomy Re-emerge as the Treatment of Choice in Patients with Advanced Prostatic Carcinoma? | Indian J Surg | 2015 | https://conductscience.org/library/papers/25829707 | PubMed |
| 25677235 | Systemic therapy for the treatment of hormone-sensitive metastatic prostate cancer: from intermittent androgen deprivation therapy to chemotherapy. | Curr Urol Rep | 2015 | https://conductscience.org/library/papers/25677235 | PubMed |
| 25371601 | Saudi oncology society and Saudi urology association combined clinical management guidelines for prostate cancer. | Urol Ann | 2014 | https://conductscience.org/library/papers/25371601 | PubMed |
| 24979481 | Non-steroidal antiandrogen monotherapy compared with luteinising hormone-releasing hormone agonists or surgical castration monotherapy for advanced prostate cancer. | Cochrane Database Syst Rev | 2014 | https://conductscience.org/library/papers/24979481 | PubMed |
| 24868335 | Efficacy of Bicalutamide 150-mg Monotherapy Compared With Combined Androgen Blockade in Patients With Locally Advanced Prostate Cancer. | Korean J Urol | 2014 | https://conductscience.org/library/papers/24868335 | PubMed |
| 24744780 | Quality of Life and Sexual Health in the Aging of PCa Survivors. | Int J Endocrinol | 2014 | https://conductscience.org/library/papers/24744780 | PubMed |
| 21789114 | Risk stratification in the hormonal treatment of patients with prostate cancer. | Ther Adv Med Oncol | 2009 | https://conductscience.org/library/papers/21789114 | PubMed |
| 21673847 | Saudi Oncology Society clinical management guidelines for prostate cancer. | Urol Ann | 2011 | https://conductscience.org/library/papers/21673847 | PubMed |
| 20091248 | The effect of androgen deprivation therapy on body composition in men with prostate cancer: systematic review and meta-analysis. | J Cancer Surviv | 2010 | https://conductscience.org/library/papers/20091248 | PubMed |
| 19290019 | Definitive radiotherapy with adjuvant long-term antiandrogen treatment for locally advanced prostate cancer: health-related quality of life and hormonal changes. | Prostate Cancer Prostatic Dis | 2009 | https://conductscience.org/library/papers/19290019 | PubMed |
| 18273599 | [Androgen deprivation for advanced prostate cancer]. | Urologe A | 2008 | https://conductscience.org/library/papers/18273599 | PubMed |
| 17971600 | Survival in men with nonmetastatic prostate cancer treated with hormone therapy: a quantitative systematic review. | J Clin Oncol | 2007 | https://conductscience.org/library/papers/17971600 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/9510340
GET https://conductscience.org/api/papers/v1/9510340/cited_by?page=2